✦ LIBER ✦
Safety and efficacy of 40 kDa peginterferon alfa-2A (PEGASYS®) in the treatment of patients co-infected with HIV and HCV: preliminary results from randomized, multicenter trial: Mandana Khalili, University of California, San Francisco, San Francisco, CA; Margaret Hoffman-Terry, Lehigh Valley Hospital, Allentown, PA; Tarek I Hassanein, University of California, San Diego, San Diego, CA; David E Bernstein, North Shore University Hospital, Manhasset, NY; George E Harb, David Pearson, Roche Laboratories Inc, Nutley, NJ
- Book ID
- 118689003
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 222 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.